[18F]MC225-PET
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [18F]MC225-PET, covering 2023-05-10 to 2023-05-10. Get the full timeline:
Most recent: Clinical Trial Update: [18F]MC225-PET in Neurodegenerative Disease [Phase 1, Phase 2]